DAXXIFY

Revance Therapeutics, Inc

Application Filed: 2020-03-30
Trademark Application Details
Trademark Logo DAXXIFY

Mark For: DAXXIFY® trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes. [all]

Status

2021-09-23 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88852845
Registration Number1551104
Mark Literal ElementsDAXXIFY
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2020-09-22
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameMaren C. Perry
Attorney Docket Number13720.104073

Timeline

2020-03-30Application Filed
2020-04-02Location: NEW APPLICATION PROCESSING
2020-04-02Status: Live/Pending
2020-04-02Transaction Date
2020-07-28Published
2020-09-22Location: INTENT TO USE SECTION
2021-09-01Status: A second request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: Revance Therapeutics, Inc
Address7555 Gateway Blvd. Newark, CALIFORNIA UNITED STATES 94560
Legal Entity TypeCorporation
Legal Entity StateDELAWARE
Party: Revance Therapeutics, Inc.
Address7555 Gateway Blvd. Newark, CALIFORNIA UNITED STATES 94560
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

*multiple parties listed, check assignment documents for ownership information

Attorney of Record

MAREN C. PERRY
KING & SPALDING LLP
1185 AVENUE OF THE AMERICAS
NEW YORK, NY 10036

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-09-03
TEAS EXTENSION RECEIVED2021-09-01
EXTENSION 2 GRANTED2021-09-0198765
EXTENSION 2 FILED2021-09-0198765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-02-17
TEAS EXTENSION RECEIVED2021-02-15
EXTENSION 1 GRANTED2021-02-1598765
EXTENSION 1 FILED2021-02-1598765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2020-09-22
CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED2020-08-0667832
ASSIGNED TO PETITION STAFF2020-08-0667832
PUBLISHED FOR OPPOSITION2020-07-28
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2020-07-28
TEAS POST PUBLICATION AMENDMENT RECEIVED2020-07-161111
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2020-07-08
ASSIGNED TO EXAMINER2020-06-1993661
APPROVED FOR PUB - PRINCIPAL REGISTER2020-06-19
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2020-04-04
NEW APPLICATION ENTERED IN TRAM2020-04-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed